Aprogenex to supply AproProbe DNA probes to BioSeparations for prenatal genetic test.
This article was originally published in The Gray Sheet
Executive Summary
APROGENEX/BIOSEPARATIONS PRENATAL GENETIC TEST DEVELOPMENT DEAL gives Houston-based Aprogenex a vehicle for commercialization of its AproProbe DNA probes. The companies announced Aug. 28 a supply agreement under which Aprogenex will combine its DNA probes with BioSeparations' cell enrichment/separation technology to develop tests for the identification of prenatal genetic disorders.